308 related articles for article (PubMed ID: 30442186)
1. Safety and efficacy of Momordica charantia Linnaeus in pre-diabetes and type 2 diabetes mellitus patients: a systematic review and meta-analysis protocol.
Peter EL; Deyno S; Mtewa A; Kasali FM; Nagendrappa PB; Sesaazi D; Tolo CU; Ogwang PE
Syst Rev; 2018 Nov; 7(1):192. PubMed ID: 30442186
[TBL] [Abstract][Full Text] [Related]
2. Systematic review and meta-analysis protocol for efficacy and safety of Momordica charantia L. on animal models of type 2 diabetes mellitus.
Peter EL; Mtewa AG; Nagendrappa PB; Kaligirwa A; Sesaazi CD
Syst Rev; 2020 Jan; 9(1):7. PubMed ID: 31915054
[TBL] [Abstract][Full Text] [Related]
3. Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis.
Peter EL; Kasali FM; Deyno S; Mtewa A; Nagendrappa PB; Tolo CU; Ogwang PE; Sesaazi D
J Ethnopharmacol; 2019 Mar; 231():311-324. PubMed ID: 30385422
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Momordica charantia for type 2 diabetes mellitus.
Ooi CP; Yassin Z; Hamid TA
Cochrane Database Syst Rev; 2012 Aug; (8):CD007845. PubMed ID: 22895968
[TBL] [Abstract][Full Text] [Related]
6. Momordica charantia for type 2 diabetes mellitus.
Ooi CP; Yassin Z; Hamid TA
Cochrane Database Syst Rev; 2010 Feb; (2):CD007845. PubMed ID: 20166099
[TBL] [Abstract][Full Text] [Related]
7. The safety and efficacy of Momordica charantia L. in animal models of type 2 diabetes mellitus: A systematic review and meta-analysis.
Peter EL; Nagendrappa PB; Kaligirwa A; Ogwang PE; Sesaazi CD
Phytother Res; 2021 Feb; 35(2):637-656. PubMed ID: 32929814
[TBL] [Abstract][Full Text] [Related]
8. The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies.
Dans AM; Villarruz MV; Jimeno CA; Javelosa MA; Chua J; Bautista R; Velez GG
J Clin Epidemiol; 2007 Jun; 60(6):554-9. PubMed ID: 17493509
[TBL] [Abstract][Full Text] [Related]
9. Hypoglycemic efficacy and safety of Momordica charantia (bitter melon) in patients with type 2 diabetes mellitus.
Kim SK; Jung J; Jung JH; Yoon N; Kang SS; Roh GS; Hahm JR
Complement Ther Med; 2020 Aug; 52():102524. PubMed ID: 32951763
[TBL] [Abstract][Full Text] [Related]
10. Anti-diabetic agents for prevention of type 2 diabetes mellitus in people with pre-diabetes: a systematic review and network meta-analysis protocol.
Wang X; Liu J; Huang L; Zeng H; He G; Chen L; Ma R; Fu W; Ning B
BMJ Open; 2019 Oct; 9(10):e029073. PubMed ID: 31594873
[TBL] [Abstract][Full Text] [Related]
11. Relationship between serum osteocalcin/undercarboxylated osteocalcin and type 2 diabetes: a systematic review/meta-analysis study protocol.
Liu Y; Liu X; R Lewis J; Brock K; C Brennan-Speranza T; Teixeira-Pinto A
BMJ Open; 2019 Mar; 9(3):e023918. PubMed ID: 30862632
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of walking exercise on glycemic control in patients with type 2 diabetes mellitus: A protocol for systematic review and meta-analysis of randomized cross-over controlled trials.
Hu H; Lei Y; Yin L; Luo X
Medicine (Baltimore); 2020 Nov; 99(47):e22735. PubMed ID: 33217794
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of dapagliflozin combined with hypoglycemic drugs in treating type 2 diabetes: protocol for meta-analysis of randomized controlled trials.
Sun YN; Zhou Y; Chen X; Che WS; Leung SW
Syst Rev; 2013 Nov; 2():103. PubMed ID: 24225054
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of organic cation transporters 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes mellitus: a systematic review protocol.
Mato EPM; Guewo-Fokeng M; Faadiel Essop M; Owira PMO
Syst Rev; 2018 Jul; 7(1):105. PubMed ID: 30041690
[TBL] [Abstract][Full Text] [Related]
15. Comparative effectiveness of sodium-glucose co-transporter 2 inhibitors for controlling hyperglycaemia in patients with type 2 diabetes: protocol for a systematic review and network meta-analysis.
Chen M; Xie CG; Gao H; Zheng H; Chen Q; Fang JQ
BMJ Open; 2016 Jan; 6(1):e010252. PubMed ID: 26826156
[TBL] [Abstract][Full Text] [Related]
16. Potential for improved glycemic control with dietary Momordica charantia in patients with insulin resistance and pre-diabetes.
Efird JT; Choi YM; Davies SW; Mehra S; Anderson EJ; Katunga LA
Int J Environ Res Public Health; 2014 Feb; 11(2):2328-45. PubMed ID: 24566057
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of Chinese herbal medicine on blood glucose fluctuations in patients with type 2 diabetes mellitus: A protocol of systematic review and meta-analysis.
Leng Y; Zhou X; Xie Z; Hu Z; Gao H; Liu X; Xie H; Fu X; Xie C
Medicine (Baltimore); 2020 Aug; 99(34):e21904. PubMed ID: 32846855
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy in paediatric type 2 diabetes mellitus: a protocol for a systematic review and network meta-analysis of randomised trials.
Zhou F; Deng J; Banfield L; Thabane L; Sadeghirad B; Samaan MC
BMJ Open; 2022 Sep; 12(9):e065287. PubMed ID: 36167361
[TBL] [Abstract][Full Text] [Related]
19. Effects of Momordica Charantia (Karela/bitterguord) in Type 2 Diabetic Patients Taking Allopathic Drugs: A pilot study.
Rauniyar GP; Sinha R; Chapagain K; Maskey R; Pandey DR
Kathmandu Univ Med J (KUMJ); 2021; 19(74):143-147. PubMed ID: 34819444
[TBL] [Abstract][Full Text] [Related]
20. Point-of-care testing of HbA1c levels in community settings for people with established diabetes or people at risk of developing type 2 diabetes: a systematic review and meta-analysis protocol.
Gourlay A; Sutherland C; Radley A
BMJ Open; 2023 May; 13(5):e072882. PubMed ID: 37173112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
